The capsules are GMP certified and will be used in clinical trials and by authorized patients
British American Tobacco will be the joint venture's initial investor, contributing US$10M
The amount of medical cannabis patients in Utah increased by 51 per cent last year
The ruling opens J&J to further litigation for its failure to warn consumers about potential cancer risks with its talc-based products
The new venture is named after a river with great cultural significance to Indigenous peoples
Approximately 300 million people suffer from anxiety and depression while effective treatments are still limited
The company's rubber will have a 'double pocket' containing a special lubricant for enhanced intercourse
The CannQuit-N and CannQuit-O products utilize CBD to reduce anxiety and cravings
PharmAla will have exclusive rights to resell Mindset's cGMP psilocybin to designated researchers
Pathway's Medical Cannabis Management System (MCMS) will be implemented this November
Amyris will support the WWF's drive to push fishers in Ecuador and Peru towards sustainable fishing during the partnership's first year.
Here are five biotechnology and medical tech companies pooling their resources to make our lives easier.
Immunic is a biopharmaceutical company that engages in clinical-stage studies involving a pipeline of oral immunology therapies
New amendment to the Mental Health Services Protection Regulation has been initiated to effectively safeguard patients
The new products are said to work in unison with the endocannabinoid system
New study also suggests that plant-derived medicines can reduce inflammation and improve mental health
Neurology Centre of Toronto in Forest Hill expands its therapy catalogue
Eastman's aim is circularity, and collaborations like help change the industry, using molecular recycling to promote a circular healthcare economy.
Liver, lung and breast cancer were the three most prevalent cancers in Vietnam in 2020, according to the World Health Organization.
Application follows successful pre-clinical animal studies at the University of Arkansas
Flagship product from company's medical cannabis division now set for clinical trial use
Cannabinoid tablet supplier expands its Canadian distribution network
Here's a bird's eye view of the sleep technology industry.
Breast cancer is the second most common cancer among women.
Starseed Medicinal services' patient base grew over 50 per cent since 2019
The platform has been launched in Germany, France, the United Kingdom and Portugal
Its Psilly brand wants to offer functional mushroom blends, gummies and chocolates.
Clinical psychedelic sector value anticipated to ascend significantly into 2028
Impending market consolidation set to boost sales of CBD animal products across continent
This April, Pure Extracts Manufacturing Corp. received an IPO from the Nova Scotia Liquor Corporation Cannabis for its vapes and hemp-based edibles
High-grade extract creams now available at participating franchise locations in the U.S.
The company also finished acquiring 51 per cent of CannaCare Health GmbH
New academic journal spotlights potential for rare cannabinoids to treat skin conditions
Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year
Dimethyltryptamine continues to demonstrate tremendous therapeutic potential
D9-THCV one of many in company cannabinoid portfolio set to diversify and expand in coming years
Water-soluble cannabinoids provide wide-range of health benefits
More products under the IQANNA brand are expected to be introduced in the coming weeks









































